hTEE Symposium
Register for our symposium at the International Society of Heart and Lung Transplantation (ISHLT) Annual Meeting on April 24th. Speakers include:
- Margarita Camacho MD Newark Beth Israel Medical Center
- Nicholas Cavarocchi MD Thomas Jefferson University Hospital
- Claudia Gidea MD Newark Beth Israel Medical Center
- Peter Lee MD, PhD Stanford University Medical Center
Fore more information, contact us at hteebreakfast@imacorinc.com
|
CME COURSE
on hTEE
May16 Thomas Jefferson University Hospital
Contact Geeta Surti for more information at courses@imacorinc.com
|
 | | Claudia Gidea MD from Newark Beth Israel assessing a heart failure patient undergoing a VV ECMO |
|
 | | Mitch Sally MD, Fellow, Oregon Health & Science University, learning to acquire images on hTEE simulator |
|
 | | Stanford University Medical Center's Barbara Imhoff NP & Christine Hartley NP performing an hTEE exam |
|
 | Physicians discussing hTEE at our booth at ISICEM in Brussels.
|
|
Friend Us on Facebook
|
Quick Links www.ImaCorInc.com info@imacorinc.com
1.516.393.0970 or 1.877.244.0657 |
|
|
|
 
Utility of Continuously-Available Transesophageal Echocardiography (TEE) in the ICU for Patient Monitoring: A Preliminary Perspective
A. Murat Kaynar MD MPH, Dennis Phillips MD, Hernando Gomez MD, Mark Lischner MD, Samer Melhem MD, Kathirvel Subramaniam MD, Michael R. Pinsky MD, UPMC Pittsburgh, PA, USA
Presented at ISICEM 2013
(Please click to read full report)
|
An Interview with Prof. Jukka Takala: Continuity is Key to Echocardiography in Hemodynamic Sepsis Management
Liam Davenport, ISICEM Reporter
"Now, this new technology offers the possibility of  getting the basic information with a quite minimal amount of training, actually. When we introduced the technology in our unit, most of our staff had no training in esophageal echocardiography. We found out that, in fact, just with short training of a few hours' duration, you could introduce the technology so that the investigations by the staff with these devices could be performed validly.
"We did a validation study such that we recorded the performance of the staff using a standard approach for inserting the probe and to get the information. This was then re-evaluated by a trained cardiologist, an echo specialist, and we found an excellent agreement between the information obtained by the cardiologist versus our staff.
|
The Use of hTEE™ to Guide Hemodynamic Management in a Patient Undergoing Scoliosis Surgery
Steffen Rex MD, PhD, Associate Head of Clinic
University Hospitals Leuven (Belgium)
(Excerpted, please click to read full case report)
A 67-year-old female patient was scheduled for posterior correction of degenerative scoliosis reaching from the third thoracic segment down to the iliac bone. Her medical history was devoid of any cardiac risk factors. However, her preoperative electrocardiogram showed signs of an older inferior myocardial infarction. The preoperative echocardiography was inconspicuous. Our case illustrates the use of hTEE™ to aid in diagnosing the correct cause of intraoperative hypotension. Due to its miniaturization, the hTEE™ could be safely used in prone position |
|
Moreover, newly trained users obtain consistent, actionable information - here is a graph presented at ESICM, Lisbon, 2012 (Merz TM, Cioccari L, Baur HR, Takala J. Management of Hemodynamically Compromised Patients using the ImaCor ClariTEE Probe - A feasibility study). Note the excellent agreement between newly trained users and experienced cardiologists in using hTEE to assess global left ventricular contractability using fractional area change.
Read More    
Go to Top
|
24/7 hTEE Support Available
We are available to be on line to answer questions and guide you through probe placement, system operation and image optimization.
A consultative partnership dedicated to your confidence with hTEE.
|
ImaCor executed on its key initiatives in Q1 2013, driving hTEE adoption to impact more patients through sharing our users' best practices. Indeed, at hospitals such as Barnes Jewish, Henry Ford, and Newark Beth Israel, clinical teams have rallied around the hemodynamic core principles as described by Dr. Tiffany Osborne of Barnes Jewish in her testimonial. Moreover, new papers are being accepted, and we have a growing roster of cases to share. hTEE is truly making an impact in critical care. It is an honor to hear our customers speak on our behalf, and this was particularly evident at the ISICEM in March. The ISICEM newspaper spotlighted Jukka Takala, MD, PhD from Bern University Hospital on his work with hTEE. Prof. Takala spoke solely on hTEE in the Gold Hall, where he presented in the session "Hemodynamic resuscitation in sepsis". At the pre-symposium, post-graduate hemodynamic monitoring course "Making the Right Measures", Michel Slama, MD, PhD from CHU Amiens Sud provided excellent insights on hTEE feasibility and the impact hTEE has on management from his multicenter study. I left the ISICEM energized and excited by the level of enthusiasm for our hTEE technology. I offer many thanks to this distinguished group of physicians who know first-hand the value of hTEE in the clinical setting. Our next hTEE symposium will be held at ISHLT (the International Society of Heart and Lung Transplantation) in Montreal Quebec on April 24th. I am privileged to announce the presenters for this event: - Margarita Camacho, MD from Newark Beth Israel
- Nicholas Cavarocchi, MD from Thomas Jefferson University Hospital
- Claudia Gidea, MD from Newark Beth Israel
- Peter Lee, MD, PhD from Stanford University Medical Center
These presenters will provide their insights and detailed case findings on hTEE for use in cardiac support. We look forward to seeing you at the hTEE MCS Symposium on April 24th. With kind regards, Peter Pellerito President & CEO |
Recent Issues of ImaCor Newsletters
|
|
|
|
|
